{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:41:49Z","timestamp":1790264509609,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.parkreldis.2008.05.010","type":"journal-article","created":{"date-parts":[[2008,7,17]],"date-time":"2008-07-17T00:48:18Z","timestamp":1216255698000},"page":"213-219","source":"Crossref","is-referenced-by-count":47,"title":["Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number"],"prefix":"10.1016","volume":"15","author":[{"given":"B.","family":"G\u00f3mez-Ans\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Alegret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.C.","family":"Mont\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Alayrach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Boada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2008.05.010_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib2","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/archneur.57.7.1040","article-title":"Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene","volume":"57","author":"Kirkwood","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/1531-8249(200101)49:1<29::AID-ANA7>3.0.CO;2-B","article-title":"Quantitative neuropathological changes in presymptomatic Huntington's disease","volume":"49","author":"G\u00f3mez-Tortosa","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","article-title":"Onset and rate of striatal atrophy in preclinical Huntington disease","volume":"63","author":"Aylward","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/1531-8257(200005)15:3<552::AID-MDS1020>3.0.CO;2-P","article-title":"Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease","volume":"15","author":"Aylward","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1212\/01.wnl.0000176071.08694.cc","article-title":"Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease","volume":"65","author":"Van Oostrom","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1212\/01.wnl.0000174432.87383.87","article-title":"Regional cortical thinning in preclinical Huntington disease and its relationship to cognition","volume":"65","author":"Rosas","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib8","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/brain\/awf179","article-title":"The distribution of structural neuropathology in pre-clinical Huntington's disease","volume":"125","author":"Thieben","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/01.wnl.0000257090.01107.2f","article-title":"Decreased frontal choline and neuropsychological performance in preclinical Huntington disease","volume":"68","author":"Gomez-Anson","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's disease rating scale: reliability and consistency","volume":"11","year":"1996","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nimg.2002.1040","article-title":"Accurate, robust, and automated longitudinal and cross-sectional brain change analysis","volume":"17","author":"Smith","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1006\/nimg.2000.0582","article-title":"Voxel-based morphometry \u2013 the methods","volume":"11","author":"Ashburner","year":"2000","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib13","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1006\/nimg.2001.0961","article-title":"Why voxel-based morphometry should be used","volume":"14","author":"Ashburner","year":"2001","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/nimg.2001.0786","article-title":"A voxel-based morphometric study of ageing in 465 normal adult human brains","volume":"14","author":"Good","year":"2001","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib15","series-title":"Neuropsychological assessment","author":"Lezak","year":"2004"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainres.2004.10.030","article-title":"Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease","volume":"1031","author":"Reynolds","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington's disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biopsych.2005.06.003","article-title":"Brain structure in preclinical Huntington's disease","volume":"59","author":"Paulsen","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF00230496","article-title":"The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy","volume":"85","author":"Mann","year":"1993","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/cne.10938","article-title":"Evidence for progression in frontal cortical pathology in late-stage Huntington's disease","volume":"468","author":"Selemon","year":"2004","journal-title":"J\u00a0Comp Neurol"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib21","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"issue":"2-3","key":"10.1016\/j.parkreldis.2008.05.010_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainresbull.2006.10.029","article-title":"Imaging microglial activation in Huntington's disease","volume":"72","author":"Tai","year":"2007","journal-title":"Brain Res Bull"},{"issue":"Pt 7","key":"10.1016\/j.parkreldis.2008.05.010_bib23","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF00868528","article-title":"Visual processing disorders in patients with Huntington's disease and asymptomatic carriers","volume":"243","author":"G\u00f3mez-Tortosa","year":"1996","journal-title":"J Neurol"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib25","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1016\/j.visres.2004.06.006","article-title":"Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington's disease","volume":"44","author":"Blekher","year":"2004","journal-title":"Vision Res"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib26","first-page":"213","article-title":"Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study","volume":"75","author":"Kassubek","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/cercor\/bhh185","article-title":"Thalamic atrophy in Huntington's disease covaries with cognitive performance: a morphometric MRI analysis","volume":"15","author":"Kassubek","year":"2005","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jns.2005.07.007","article-title":"Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study","volume":"239","author":"Peinemann","year":"2005","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1016\/j.parkreldis.2008.05.010_bib29","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1590\/S0100-879X2006000800016","article-title":"Striatal and extrastriatal atrophy in Huntington's disease and its relationship with\u00a0length of the CAG repeat","volume":"39","author":"Ruocco","year":"2006","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.parkreldis.2008.05.010_bib30","article-title":"Longitudinal analysis of regional gray matter loss in Huntington disease: effects of the length of the CAG repeat","author":"Ruocco","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.parkreldis.2008.05.010_bib31","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/mds.21620","article-title":"Variation of selective gray and white matter atrophy in Huntington's disease","volume":"22","author":"Jech","year":"2007","journal-title":"Mov Disord"},{"issue":"140","key":"10.1016\/j.parkreldis.2008.05.010_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pscychresns.2005.05.011","article-title":"Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study","volume":"30","author":"Reading","year":"2005","journal-title":"Psychiatry Res"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802008001600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802008001600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T06:54:52Z","timestamp":1545893692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802008001600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1353802008001600"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2008.05.010","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}